AtaiBeckley Surges on Eli Lilly Acquisition Worth Up to $3.8 Billion
AtaiBeckley (ATAI) surged by 33.4% following its acquisition by Eli Lilly for up to $3.8 billion, with the deal including cash and contingent value rights tied to future milestones. The broader market saw declines in major indices like the S&P 500 and Nasdaq Composite.
